Bergenbio ASA Cash And Equivalents vs. Shares Outstanding
| BGBIO Stock | NOK 12.54 0.16 1.26% |
For Bergenbio ASA profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Bergenbio ASA to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Bergenbio ASA utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Bergenbio ASA's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Bergenbio ASA over time as well as its relative position and ranking within its peers.
Bergenbio |
Bergenbio ASA Shares Outstanding vs. Cash And Equivalents Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Bergenbio ASA's current stock value. Our valuation model uses many indicators to compare Bergenbio ASA value to that of its competitors to determine the firm's financial worth. Bergenbio ASA is number one stock in cash and equivalents category among its peers. It also is number one stock in shares outstanding category among its peers creating about 0.20 of Shares Outstanding per Cash And Equivalents. The ratio of Cash And Equivalents to Shares Outstanding for Bergenbio ASA is roughly 4.92 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Bergenbio ASA by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Bergenbio ASA's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Bergenbio Shares Outstanding vs. Cash And Equivalents
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Bergenbio ASA |
| = | 436.65 M |
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Bergenbio ASA |
| = | 88.66 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Bergenbio Shares Outstanding Comparison
Bergenbio ASA is currently under evaluation in shares outstanding category among its peers.
Bergenbio ASA Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Bergenbio ASA, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Bergenbio ASA will eventually generate negative long term returns. The profitability progress is the general direction of Bergenbio ASA's change in net profit over the period of time. It can combine multiple indicators of Bergenbio ASA, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
BerGenBio ASA, a clinical-stage biopharmaceutical company, develops medicines to treat immune evasive, drug resistant, and metastatic cancers. The company was founded in 2007 and is headquartered in Bergen, Norway. BerGenBio ASA is traded on Oslo Stock Exchange in Norway.
Bergenbio Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Bergenbio ASA. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Bergenbio ASA position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Bergenbio ASA's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Bergenbio ASA without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Analyst Advice Now
Analyst AdviceAnalyst recommendations and target price estimates broken down by several categories |
| All Next | Launch Module |
Use Investing Themes to Complement your Bergenbio ASA position
In addition to having Bergenbio ASA in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Retail Thematic Idea Now
Retail
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Retail theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Retail Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Bergenbio Stock
To fully project Bergenbio ASA's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Bergenbio ASA at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Bergenbio ASA's income statement, its balance sheet, and the statement of cash flows.